AssureMDx is a multi-omics, liquid biopsy urine test designed to triage patients with hematuria who are at risk for bladder cancer and to monitor for recurrence in post-treatment patients. It is offered as a laboratory-developed test (LDT) performed in the company's CLIA-certified, CAP-accredited laboratory.